Skip to main content
. 2012 Jul 1;55(10):2613–2621. doi: 10.1007/s00125-012-2633-y

Table 3.

RR of type 2 diabetes (95% CI) according to serum ferritin, sTfR and the ratio of sTfR to ferritin

Risk factor RR (95% CI) p trend
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5
Ferritin
 Men, mg/l <8.00 8.00 to <13.0 13.0 to <19.0 19.0 to <28.0 ≥28.0
 Women, mg/l <2.00 2.00 to <3.89 3.89 to <6.39 6.39 to <11.0 ≥11.0
 Model 1 1 0.95 (0.59, 1.50) 1.49 (1.00, 2.24) 1.54 (1.03, 2.31) 2.00 (1.35, 2.95) <0.001
 Model 1 + hs-CRP 1 1.01 (0.63, 1.63) 1.56 (1.03, 2.37) 1.65 (1.09, 2.50) 2.09 (1.40, 3.12) <0.001
 Model 1 + GGT and ALT 1 0.91 (0.57, 1.46) 1.45 (0.97, 2.17) 1.51 (1.01, 2.26) 1.74 (1.17, 2.60) <0.001
 Model 1 + fetuin-A 1 0.94 (0.59, 1.51) 1.53 (1.01, 2.30) 1.58 (1.05, 2.38) 2.13 (1.43, 3.16) <0.001
 Model 1 + adiponectin 1 0.92 (0.57, 1.49) 1.52 (1.00, 2.30) 1.55 (1.03, 2.33) 1.95 (1.31, 2.90) <0.001
 Model 1 + HDL-cholesterol, triacylglycerol 1 1.00 (0.62, 1.61) 1.49 (0.99, 2.25) 1.49 (0.99, 2.23) 1.80 (1.22, 2.66) <0.001
 Model 2 1 1.00 (0.61, 1.65) 1.49 (0.97, 2.30) 1.59 (1.05, 2.42) 1.73 (1.15, 2.61) 0.002
sTfR
 Men, mg/l <0.90 0.90 to <1.00 1.00 to <1.10 1.10 to <1.30 ≥1.30
 Women, mg/l <0.80 0.80 to <0.89 0.89 to <1.00 1.00 to <1.20 ≥1.20
 Model 1 1 1.37 (0.89, 2.12) 1.83 (1.20, 2.79) 1.52 (1.03, 2.24) 1.22 (0.81, 1.86) 0.64
 Model 1 + hs-CRP 1 1.42 (0.92, 2.19) 1.87 (1.23, 2.85) 1.51 (1.02, 2.23) 1.18 (0.78, 1.80) 0.85
 Model 1 + GGT and ALT 1 1.33 (0.86, 2.07) 1.81 (1.19, 2.76) 1.46 (0.99, 2.16) 1.19 (0.78, 1.81) 0.75
 Model 1 + fetuin-A 1 1.36 (0.88, 2.10) 1.78 (1.17, 2.71) 1.48 (1.00, 2.18) 1.14 (0.75, 1.73) 0.94
 Model 1 + adiponectin 1 1.40 (0.89, 2.20) 1.81 (1.17, 2.81) 1.63 (1.09, 2.45) 1.30 (0.84, 2.00) 0.38
 Model 1 + HDL-cholesterol, triacylglycerol 1 1.47 (0.94, 2.30) 1.93 (1.25, 2.97) 1.50 (1.00, 2.23) 1.36 (0.89, 2.08) 0.47
 Model 2 1 1.38 (0.86, 2.20) 1.87 (1.20, 2.93) 1.47 (0.97, 2.22) 1.21 (0.78, 1.89) 0.80
sTfR-to-ferritin ratio
 Men, (mg/l)/(mg/l) <0.04 0.04 to <0.05 0.05 to <0.08 0.08 to <0.13 ≥0.13
 Women, (mg/l)/(mg/l) <0.09 0.09 to <0.15 0.15 to <0.25 0.25 to <0.50 ≥0.50
 Model 1 1 0.66 (0.48, 0.90) 0.59 (0.43, 0.82) 0.63 (0.45, 0.88) 0.50 (0.34, 0.73) <0.001
 Model 1 + hs-CRP 1 0.67 (0.49, 0.91) 0.59 (0.42, 0.82) 0.63 (0.45, 0.89) 0.47 (0.32, 0.70) <0.001
 Model 1 + GGT and ALT 1 0.72 (0.52, 0.99) 0.66 (0.47, 0.91) 0.69 (0.49, 0.98) 0.56 (0.38, 0.83) 0.004
 Model 1 + fetuin-A 1 0.64 (0.46, 0.87) 0.57 (0.41, 0.79) 0.58 (0.41, 0.82) 0.46 (0.32, 0.68) <0.001
 Model 1 + adiponectin 1 0.71 (0.51, 0.97) 0.62 (0.44, 0.87) 0.64 (0.45, 0.92) 0.52 (0.35, 0.76) <0.001
 Model 1 + HDL-cholesterol, triacylglycerol 1 0.69 (0.50, 0.95) 0.64 (0.46, 0.89) 0.71 (0.50, 1.00) 0.55 (0.37, 0.80) 0.002
 Model 2 1 0.76 (0.54, 1.06) 0.67 (0.47, 0.96) 0.70 (0.48, 1.02) 0.57 (0.38, 0.85) 0.005

Model 1 is adjusted for age, sex, BMI, waist circumference, sports activity, bicycling, education, occupational activity, smoking habit and alcohol consumption

Model 2 is adjusted for factors in model 1 and GGT, ALT, fetuin-A, hs-CRP, adiponectin, HDL-cholesterol and triacylglycerol concentrations